MEDIFAST INC

Listed Company

MEDCIK 0000910329NYSEAcceleratedSmaller ReportingMiscellaneous Food Preparations & Kindred ProductsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$385.79M

Net Income

$-18.67M

Total Assets

$247.97M

Equity

$198.92M

Shares Out

11.12M

Op. Cash Flow

$6.86M

MED$10.25−23.69% · past yearDBEQ Basic

Daily closing prices

Business

Medifast Inc. is a health and wellness company offering a science-backed, coach-guided lifestyle system to address metabolic health and weight loss. The company provides clinically proven nutrition plans and scientifically developed products including OPTAVIA Fuelings, OPTAVIA ACTIVE, and OPTAVIA ASCEND, paired with personalized coaching from independent contractors, most of whom transitioned from being clients. Medifast operates primarily in the U.S. through a direct-to-consumer model where coaches support clients via word-of-mouth and social media, with products shipped directly to end consumers.

Summary from 10-K filed 2026-02-17

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	386	602	1,072	1,599	1,526
Cost of sales	111	158	296	458	398
Gross profit	275	445	776	1,140	1,128
Selling, general, and administrative	289	442	649	956	911
Income (loss) from operations	−14	3	126	185	216
Interest income	6	5	2	−701,000	−231,000
Other income (expense)	3	−4	−95,000	−46,000	119,000
Total other income (expense)	9	909,000	2	−747,000	−112,000
Income (loss) before provision for income taxes	−6	4	129	184	216
Income Tax Expense (Benefit)	13	2	29	40	52
Net income (loss)	−19	2	99	144	164
Basic (in usd per share)	−1.7	0.19	9.13	12.82	14.01
Diluted (in usd per share)	−1.7	0.19	9.1	12.73	13.89
Basic (in shares)	11	11	11	11	12
Diluted (in shares)	11	11	11	11	12
Cash dividends declared per share (in usd per share)	0	0	4.95	6.56	5.68

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	89	91	94	88	104
Inventories, net	20	42	55	119	180
Investments	78	71	56	0	5
Income taxes, prepaid	5	0	9	0	945,000
Prepaid expenses and other current assets	9	10	11	16	16
Total current assets	202	214	224	223	307
Property, plant and equipment - net of accumulated depreciation	31	38	51	57	56
Right-of-use assets	7	11	16	18	24
Other assets	8	10	15	12	6
Deferred tax assets, net	0	11	4	5	4
TOTAL ASSETS	248	284	310	316	398
Accounts payable and accrued expenses	38	56	86	135	163
Income taxes payable	0	1	—	—	—
Current lease obligations	5	6	6	6	7
Total current liabilities	43	64	92	141	170
Lease obligations, net of current lease obligations	6	10	16	20	26
Total liabilities	49	74	108	161	196
Commitments (Note 12)	—	—	—	—	—
Common stock, par value 0.001 per share: 20,000 shares authorized; 10,991 and 10,938 issued and outstanding at December 31, 2025 and December 31, 2024	11,000	11,000	11,000	11,000	12,000
Additional paid-in capital	40	33	27	22	12
Accumulated other comprehensive income	234,000	180,000	248,000	24,000	111,000
Retained earnings	158	177	175	140	190
Total stockholders' equity	199	210	201	155	202
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	248	284	310	316	398
Common stock, outstanding (in shares)	11	11	11	11	12

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	14	13	13	11	7
Non-cash lease expense	5	4	5	6	5
Share-based compensation	8	7	8	11	10
Loss on sale of disposal of property, plant and equipment	1	89,000	1	2	2,000
Realized gain on sale of investment securities	−3	−95,000	0	0	—
Amortization of discount on investment securities	−671,000	−799,000	−169,000	14,000	89,000
Deferred income taxes	11	−7	1	−924,000	−4
Unrealized (gain) loss on equity investment securities	−17,000	4	−150,000	0	—
Non-cash charges for supply chain optimization	0	12	0	0	—
Inventories	22	12	64	61	−127
Income taxes	−7	10	−9	1	−945,000
Prepaid expenses and other current assets	573,000	2	6	97,000	−10
Other assets	−2	396,000	−5	−3	−5
Accounts payable and accrued expenses	−24	−35	−36	−38	54
Net cash flow provided by operating activities	7	24	148	195	95
Purchase of investment securities	−84	−47	−60	0	0
Proceeds from sale and maturities of investment securities	82	28	5	5	5
Purchase of property and equipment	−6	−7	−6	−17	−34
Net cash flow used in investing activities	−8	−27	−61	−11	−29
Options exercised by executives and directors	0	36,000	188,000	0	800,000
Net shares repurchased for employee taxes	−369,000	−836,000	−3	−2	−6
Cash dividends paid to stockholders	−195,000	−715,000	−73	−72	−64
Stock repurchases	0	0	−4	−126	−56
Net cash flow used in financing activities	−564,000	−2	−80	−200	−125
Foreign currency impact	4,000	47,000	−72,000	−67,000	112,000
Increase (Decrease) in cash and cash equivalents	−2	−4	7	−16	−60
Income taxes (refunded) paid	11	−2	34	37	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is MEDIFAST INC's CIK number?

MEDIFAST INC's SEC CIK number is 0000910329 (910329). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find MEDIFAST INC's SEC filings?

All of MEDIFAST INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did MEDIFAST INC last report earnings?

MEDIFAST INC (MED) most recently filed an earnings 8-K with the SEC on May 4, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-029812). This is MEDIFAST INC's most recent earnings filing of record — not a forecast of its next earnings date.

What is MEDIFAST INC's most recent earnings 8-K?

MEDIFAST INC's latest earnings 8-K (Item 2.02) was filed May 4, 2026 under accession 0001628280-26-029812. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View MEDIFAST INC's latest earnings 8-K →
Look up any company's CIK number →